Pagaya Technologies Ltd. ( PGY ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants Josh Fagen - Head of Investor Relations & COO of Finance Gal Krubiner - CEO, Co-Founder & Director Sanjiv Das - Co-Founder & President Evangelos Perros - Chief Financial Officer Conference Call Participants John Hecht - Jefferies LLC, Research Division Peter Christiansen - Citigroup Inc., Research Division Harold Goetsch - B.

YPF Sociedad Anónima ( YPF ) Q3 2025 Earnings Call November 10, 2025 9:00 AM EST Company Participants Margarita Chun - Investor Relations Officer Horacio Marin - CEO & Non Independent Chairman Maximiliano Westen - Strategy, New Businesses and Controlling Vice President Pedro Kearney - Vice President of Finance Conference Call Participants Alejandro Anibal Demichelis - Jefferies LLC, Research Division Leonardo Marcondes - BofA Securities, Research Division Daniel Guardiola - Banco BTG Pactual S.A., Research Division Guilherme Costa Martins - Goldman Sachs Group, Inc., Research Division Tasso Vasconcellos - UBS Investment Bank, Research Division Presentation Margarita Chun Investor Relations Officer …

Repligen Corporation ( RGEN ) UBS Global Healthcare Conference 2025 November 10, 2025 11:00 AM EST Company Participants Jason Garland - CFO & Chief Compliance Officer Jacob Johnson - Vice President of Investor Relations Conference Call Participants Daniel Leonard - UBS Investment Bank, Research Division Presentation Daniel Leonard UBS Investment Bank, Research Division All right. With that, we're ready to kick things off.

Cogent Biosciences, Inc. ( COGT ) Discusses Positive Phase 3 PEAK Trial Results of Bezuclastinib in Gastrointestinal Stromal Tumors November 10, 2025 8:00 AM EST Company Participants Christi Waarich - Senior Director of Investor Relations Andrew Robbins - President, CEO & Director Conference Call Participants Neeta Somaiah Anupam Rama - JPMorgan Chase & Co, Research Division Paul Jeng - Guggenheim Securities, LLC, Research Division Amanda Acosta-Ruiz - Leerink Partners LLC, Research Division Samuel Slutsky - LifeSci Capital, LLC, Research Division Christopher Raymond - Raymond James & Associates, Inc., Research Division Yuxi Dong - Jefferies LLC, Research Division Presentation Operator Good …

For a company that practically prints cash, Amazon.com Inc. (NASDAQ:AMZN) might soon need Wall Street's help again. The e-commerce and cloud giant has not issued a major bond deal since 2021, when it raised $18.5 billion to fund the MGM acquisition — its last significant borrowing in over four years.

MINNEAPOLIS , Nov. 10, 2025 /PRNewswire/ -- Northborne Partners is pleased to announce that it served as financial advisor to Tumac Lumber Company ("Tumac") in connection with the sale of its subsidiary, Disdero Lumber Company ("Disdero"), to BlueLinx Holdings ("BlueLinx"). Founded in 1953 and headquartered in Clackamas, Oregon, Disdero is a leading value-added wholesale distributor of a broad range of premium specialty forest products and other premium building materials used primarily in the construction of custom single-family homes and high-end multi-family residential projects.

NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) for violations of the federal securities laws on behalf of investors who purchased or acquired Baxter securities between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”).

As markets hit highs and AI stocks dominate the headlines, is the rally running on fumes? The Financial Prophet, Victor Dergunov, breaks down the risks of overheated technicals, stretched valuations, and the growing disconnect between Wall Street and the real economy.

AstraZeneca Plc (NASDAQ:AZN) shared on Monday full data from the Bax24 Phase 3 trial of once-daily 2mg baxdrostat versus placebo, on the reduction of ambulatory systolic blood pressure (SBP), as well as safety and tolerability in participants with resistant hypertension.

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) on Sunday shared results from the pivotal Phase 3 CORE and CORE2 studies of olezarsen for severe hypertriglyceridemia (sHTG), a condition characterized by dangerously high triglyceride (fat) levels.

SOUN posts 68% revenue growth in the third quarter, raises guidance as enterprise AI demand fuels momentum toward breakeven in 2026.

TSN posts a strong Q4 with higher earnings and sales driven by pricing gains, showcasing the strength of its diversified protein portfolio.

PNC commits about $2B to open 300+ new branches by 2030, expanding in key U.S. markets and boosting community access.

RGTI secures $5.7M in Novera system orders and India MOU, but Q3 will test if momentum can turn into real revenue growth.

MKC leans on its CCI program savings to offset cost pressures and drive steady EPS growth in fiscal 2025.

The Zacks Electronics - Miscellaneous Components industry players like TEL, NVT and FN are benefiting from the solid adoption of AI and the democratization of IoT.

SAN DIEGO , Nov. 10, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Inspire Medical Systems, Inc. (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, both dates inclusive (the "Class Period"), have until January 5, 2026 to seek appointment as lead plaintiff of the Inspire Medical class action lawsuit. Captioned City of Pontiac Reestablished General Employees' Retirement System v.

KBR Investors with Losses Encouraged to Contact Hagens Berman Before Nov. 18th Deadline San Francisco, California--(Newsfile Corp. - November 10, 2025) - A pending class-action lawsuit targeting KBR, Inc. (NYSE: KBR) alleges that the company made misleading statements to investors in the weeks leading up to the abrupt cancellation of a major military contract which negatively impacted the company's business prospects. The lawsuit seeks to represent investors who purchased or otherwise acquired KBR securities between May 6, 2025 and June 19, 2025.

Surgery Partners, Inc. ( SGRY ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants David Doherty - Executive VP & CFO J. Evans - CEO & Director Conference Call Participants Brian Tanquilut - Jefferies LLC, Research Division Joanna Gajuk - BofA Securities, Research Division Benjamin Rossi - JPMorgan Chase & Co, Research Division Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Andrew Mok - Barclays Bank PLC, Research Division Sarah James - Cantor Fitzgerald & Co., Research Division Benjamin Mayo - Leerink Partners LLC, Research Division William …

Webcast Recording and Symposium Slides Now Available LAWRENCEVILLE, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) -- IMUNON , Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today hosted a compelling public webcast, where cancer key opinion leaders, principal investigators from the Phase 3 OVATION 3 and Phase 2 minimal residual disease (MRD) trials, clinicians, statistical experts and IMUNON executives shared critical insights into the disease and translational data, along with compelling clinical data highlighting the significant potential of IMNN-001 for women with advanced ovarian cancer.